Login
$CMPS
$8.35 +$0.08 (0.95%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Kabir Nath Also a director
Chief Executive Officer, Director
61 Not stated $2,104,710
Teri Loxam
Chief Financial Officer
54 Since 2024
2 years
$1,097,749
Guy Goodwin
Chief Medical Officer
78 Since 2021
5 years
$908,954

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Average tenure
3.8 years
from year joined
CEO also chairs the board
No
Gino Santini
Director Age On board Committees Other public boards 2025 pay Source
Gino Santini
69 2024
2 years
Compensation and Leadership Development Committee Nominating and Corporate Governance Committee · Chair
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) $232,802
Kabir Nath
61 2022
4 years
None stated None stated Paid as CEO
Justin Gover
55 2025
1 year
Audit and Risk Committee Scientific Committee
Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $187,653
Jeffrey Jonas
73 2025
1 year
Audit and Risk Committee Scientific Committee
None stated Not stated
Daphne Karydas
53 2023
3 years
Audit and Risk Committee · Chair
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) $145,826
Robert McQuade
69 2020
6 years
Audit and Risk Committee
Camurus (NASDAQ STO: CAMX) $143,868
David Norton
74 2018
8 years
Nominating and Corporate Governance Committee
None stated $134,735
Wayne Riley
66 2021
5 years
Nominating and Corporate Governance Committee
HCA Healthcare Inc. (NYSE: HCA) $136,201
Annalisa Jenkins Leaving at the meeting
60 Not stated
Compensation and Leadership Development Committee · Chair
None stated $146,921
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 15, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support